All In MedTech

PMA device

POLARx/POLARx FIT Cryoablation Catheters

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

3

PMA pathway

Device trials

4

Naming "POLARx POLARx FIT"

MAUDE reports

2

Brand "POLARx POLARx FIT", since 2015

PubMed studies

0

Mentioning "POLARx POLARx FIT"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing POLARx/POLARx FIT Cryoablation Catheters

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 3 of 3 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "POLARx POLARx FIT", any status and sponsor, newest update first.

Open in Trial Radar
  • Boston Scientific CorporationPublic (BSX)

    NCT06170606 · 200 participants · Start Jun 28, 2024 · Primary completion May 20, 2026

    Device: Boston Scientific Cardiac Cryoablation System · For: Paroxysmal Atrial Fibrillation

    Sites: Gilbert, Arizona; Phoenix, Arizona; Tucson, Arizona · 11 sites in all

  • Erasmus Medical CenterAcademic, hospital or other

    NCT05881733 · 20 participants · Start Oct 2, 2023 · Primary completion Apr 29, 2024

    Device: POLARx FIT cryoballoon · For: Atrial Fibrillation

    Sites: Rotterdam, Netherlands

  • Universitair Ziekenhuis BrusselAcademic, hospital or other

    NCT07100834 · 269 participants · Start Sep 27, 2023 · Primary completion May 30, 2024

    Device: Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System); Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA) · For: Atril Fibrillation; Cardiac Arrhythmia; Paroxysmal Atrial Fibrillation (PAF)

    Sites: Brussels, Belgium; Zagreb, Croatia; Athens, Greece · 6 sites in all

1 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "POLARx POLARx FIT", and for the whole product code for context.

This brand

2 reports: 0 malfunction, 2 injury, 0 death

Whole product code OAE

11,261 reports: 5,551 malfunction, 5,370 injury, 334 death

Newest reports for this brand

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

4 more recall records with a free account

Published research

The most relevant PubMed records for "POLARx POLARx FIT"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code OAE.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.